PMID- 11045937 OWN - NLM STAT- MEDLINE DCOM- 20001228 LR - 20200930 IS - 0363-6135 (Print) IS - 0363-6135 (Linking) VI - 279 IP - 5 DP - 2000 Nov TI - Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. PG - H2053-61 AB - Inflammatory mediators of sepsis induce apoptosis in many cell lines. We tested the hypothesis that lipopolysaccharide (LPS) injection in vivo results in induction of early apoptotic and survival pathways as well as evidence of late-stage apoptosis in the heart. Hearts were collected from control rats and at 6, 12, and 24 h after LPS injection (4 mg/kg). Activation of an apoptotic pathway was identified by a 1,000-fold increase in caspase-3 activity at 24 h (P < 0.05). Confirmation of these results occurred when terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining identified myocardial cells undergoing DNA fragmentation with significant levels at 24 h post-LPS injection. LPS also caused early proapoptotic mRNA (Bax) to increase (16% at 24 h, P < 0.05), whereas the Bax protein initially decreased (35% at 6 h, P < 0.05) and then returned to baseline values by 24 h. Six hours after LPS injection, Bcl-2 (early prosurvival) mRNA levels increased, whereas its protein levels decreased (70%, P < 0.05) and then returned to baseline levels by 24 h. Mitochondrial cytochrome c levels decreased, suggestive of mitochondrial involvement. Thus involvement of proapoptotic and prosurvival pathways in the heart occurs during a septic inflammatory response. FAU - McDonald, T E AU - McDonald TE AD - University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, British Columbia, Canada. FAU - Grinman, M N AU - Grinman MN FAU - Carthy, C M AU - Carthy CM FAU - Walley, K R AU - Walley KR LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Am J Physiol Heart Circ Physiol JT - American journal of physiology. Heart and circulatory physiology JID - 100901228 RN - 0 (Bax protein, rat) RN - 0 (Endotoxins) RN - 0 (Lipopolysaccharides) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (RNA, Messenger) RN - 0 (bcl-2-Associated X Protein) RN - EC 3.4.22.- (Casp3 protein, rat) RN - EC 3.4.22.- (Caspase 3) RN - EC 3.4.22.- (Caspases) SB - IM MH - Animals MH - *Apoptosis MH - Caspase 3 MH - Caspases/metabolism MH - Cell Survival/physiology MH - DNA Fragmentation MH - Disease Models, Animal MH - Endotoxins MH - Lipopolysaccharides MH - Male MH - Myocardium/*metabolism/pathology MH - Proto-Oncogene Proteins/genetics/metabolism MH - Proto-Oncogene Proteins c-bcl-2/genetics/metabolism MH - RNA, Messenger/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Sepsis/chemically induced/*metabolism MH - bcl-2-Associated X Protein EDAT- 2000/10/25 11:00 MHDA- 2001/02/28 10:01 CRDT- 2000/10/25 11:00 PHST- 2000/10/25 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/10/25 11:00 [entrez] AID - 10.1152/ajpheart.2000.279.5.H2053 [doi] PST - ppublish SO - Am J Physiol Heart Circ Physiol. 2000 Nov;279(5):H2053-61. doi: 10.1152/ajpheart.2000.279.5.H2053.